In this episode, I talk with Dr. Andy Abril, Chair at the Division of Rheumatology at the Mayo Clinic in Jacksonville Florida.  Dr. Abril is one of the lead authors for the 2021 ACR Guidelines on  Takayasu’s arteritis.

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

In this episode, I talk with Dr. Jason Springer, Co-Director of the Vanderbilt Vasculitis Center, about the guidelines for PAN  He is one of the lead authors for the ACR/VF Guidelines for Polyarteritis Nodosa.

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

On today's episode I discuss GCA with Dr. Mehrdad Maz.  He is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section and served on the Steering Core Committee of the ACR-VF Vasculitis Treatment Guidelines. We cover a lot of great topics!

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

In today's episode, I talk with Dr. Mehrdad Maz about the newly published guidelines for giant cell arteritis (GCA).  Dr. Maz is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section. He serves on the Steering Core Committee of the ACR-VF Vasculitis Treatment Guidelines. 

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

The guidelines have finally arrived!  I'm kicking off the series today with a conversation about the ANCA vasculitis guidelines.  My guest is Dr. Sharon Chung, the director of the UCSF Vasculitis Clinic and the lead investigator on the ACR/Guideline committee. She provided a LOT of great insights; have a listen and let us know what you think! 

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

Hopping in this week to round out my thoughts on ADVOCATE (avacopan in AAV) and covering the recently published AURORA trial for SLE nephritis. Back to the Vasculitis Guidelines Podcast after as soon as they are released! 

In this episode we'll be introducing the process by which the 2021 ACR/VF guidelines were produced.  My guest is Dr. Sharon Chung.  She's the director of the UCSF Vasculitis Clinic and the lead investigator on the guideline committee.  Please follow along with future episodes - you can find me @ebrheum and the Vasculitis Foundation is at @vasculitisfound and their website vasculitisfoundation.org.

Welcome to the first episode of the Vasculitis Guidelines Podcast! In Episode 1, I interview Joyce  Kullman, Executive Director of the Vasculitis Foundation, about collaborating with the ACR in updating these guidelines, and how patients with vasculitis will ultimately benefit from them. We discuss the complex process of updating these critical guidelines involve years of input from researchers, physicians, and patient themselves.

Quick update on a new series! 

Steroid free remission! Or is it? This week I discuss a really exciting trial in ANCA vasculitis.